Experience with biologics for psoriasis in daily practice: Switching is worth a try

British Journal of Dermatology

Volumn 161, Issue 4, 2009, Pages 948-951

  Lecluse, L L A ^a   De Groot, M ^a   Bos, J D ^a   Spuls, P I ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Biological therapies; Biologics; Psoriasis; Switch; Transition

Indexed keywords

ADALIMUMAB; EFALIZUMAB; ETANERCEPT; INFLIXIMAB; METHOTREXATE;

BIOLOGICAL THERAPY; DISEASE REGISTRY; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; LETTER; LOW DRUG DOSE; PRIORITY JOURNAL; PSORIASIS; PSORIASIS SEVERITY INDEX;

ADULT; AGED; ANTIBODIES, MONOCLONAL; BODY MASS INDEX; DERMATOLOGIC AGENTS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX;

EID: 70349323598     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09384.x     Document Type: Letter

References (10)

1. de Groot M, Appelman M, Spuls PI et al. Initial experience with routine administration of etanercept in psoriasis. Br J Dermatol 2006 155 : 808 814.
2. Selenko-Gebauer N, Karlhofer F, Stingl G. Efalizumab in routine use: a clinical experience. Br J Dermatol 2007 156 (Suppl. 2 1 6.
3. Warren RB, Brown BC, Lavery D et al. Biologic therapies for psoriasis: practical experience in a U.K. tertiary referral centre. Br J Dermatol 2009 160 : 162 169.
4. Driessen RJ, de Jong EM, de Rie MA et al. Analysis of 3-year national reimbursement application data on etanercept and efalizumab for psoriasis. Br J Dermatol 2008 159 : 760 761.
5. Papp KA, Tyring S, Lahfa M et al. A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction. Br J Dermatol 2005 152 : 1304 1312.
6. Lecluse LL, Piskin G, Mekkes JR et al. Review and expert opinion on prevention and treatment of infliximab-related infusion reactions. Br J Dermatol 2008 159 : 527 536.
7. van Vollenhoven RF. Switching between anti-tumour necrosis factors: trying to get a handle on a complex issue. Ann Rheum Dis 2007 66 : 849 851.
8. Clark L, Lebwohl M. The effect of weight on the efficacy of biologic therapy in patients with psoriasis. J Am Acad Dermatol 2008 58 : 443 446.
9. Wolbink GJ, Vis M, Lems W et al. Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis. Arthritis Rheum 2006 54 : 711 715.
10. Lecluse LL, Naldi L, Stern RS et al. National registries of systemic treatment for psoriasis and the European 'Psonet' initiative. Dermatology 2009 218 : 347 356.